Visuospatial processing in children with neurofibromatosis type 1

Neuropsychologia

Volumn 46, Issue 2, 2008, Pages 690-697

  Clements Stephens, Amy M ^a   Rimrodt, Sheryl L ^a,b   Gaur, Pooja ^a   Cutting, Laurie E ^a,b,c,d  

^a KENNEDY KRIEGER INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Johns Hopkins University   (United States)

^d HASKINS LABORATORIES   (United States)

Author keywords

fMRI; Judgment of Line Orientation (JLO); Neurofibromatosis; Visuospatial processing

Indexed keywords

ADOLESCENT; ARTICLE; BRAIN INJURY; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DEPTH PERCEPTION; ELECTROENCEPHALOGRAM; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; LEFT HEMISPHERE; MALE; MULTIVARIATE ANALYSIS OF VARIANCE; NEUROFIBROMATOSIS; NEUROIMAGING; SCHOOL CHILD; VISUAL CORTEX;

ADOLESCENT; ANALYSIS OF VARIANCE; ATTENTION; CASE-CONTROL STUDIES; CEREBRAL CORTEX; CHILD; CHILD DEVELOPMENT; FEMALE; FUNCTIONAL LATERALITY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROFIBROMATOSIS 1; ORIENTATION; PERCEPTUAL DISORDERS; REFERENCE VALUES; SPACE PERCEPTION; VISUAL PERCEPTION;

EID: 38749104239     PISSN: 00283932     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropsychologia.2007.09.013     Document Type: Article

References (30)

1. Achenbach T.M. Manual for the child behavior checklist (Parent form) (1991), University Associated in Psychiatry, Burlington, VT
2. Benton A.L., Hamsher K.D., Varney N.R., and Spreen O. Judgment of line orientation. Contributions to Neuropsychological Assessment (1983), Oxford University Press, New York
3. Billingsley R.L., Jackson E.F., Slopis J.M., Swank P.R., Mahankali S., and Moore B.D. Functional MRI of visual-spatial processing in neurofibromatosis, type I. Neuropsychologia 42 (2004) 395-404
4. Calhoun V., Adali T., Kraut M., and Pearlson G. A weighted least-squares algorithm for estimation and visualization of relative latencies in event-related functional MRI. Magnetic Resonance Medicine 44 (2000) 947-954
5. Conners C.K. Conners rating scales revised (1997), Multi-Health Systems, Niagara Falls, NY
6. Cutting L.E., Clements A.M., Lightman A.D., Yerby-Hammock P.D., and Denckla M.B. Cognitive profile of neurofibromatosis type 1: Rethinking non-verbal learning disabilities. Learning Disabilities Research & Practice 19 3 (2004) 155-165
7. Cutting L.E., Koth C.W., and Denckla M.B. How children with neurofibromatosis type 1 differ from "typical" learning disabled clinic attenders: Nonverbal learning disabilities revisited. Developmental Neuropsychology 17 (2000) 29-47
8. DuPaul G.J. Parent and teacher ratings of ADHD symptoms: Psychometric properties in a community based sample. Journal of Clinical Child Psychology 20 (1991) 243-253
9. Eden G.F., Stein J.F., Wood H.M., and Wodd F.B. Visuospatial judgment in reading disabled and normal children. Perceptual and Motor Skills 82 (1996) 155-177
10. Feldman R., Denecke J., Grenzebach M., Schuierer G., and Weglage J. Neurofibromatosis type 1: Motor and cognitive function and T2-weighted MRI hyperintensities. Neurology 61 (2003) 1725-1728
11. Goh W.H., Khong P.L., Leung C.S., and Wong V.C. T2-weighted hyperintensities (unidentified bright objects) in children with neurofibromatosis type 1: Their impact on cognitive function. Journal of Child Neurology 19 (2004) 853-858
12. Hammill D.D., Pearson N.A., and Voress J.K. Developmental Test of Visual Perception. 2nd ed. (1993), PRO-ED Inc., Austin, TX
13. Hofman K.J., Harris E.L., Bryan R.N., and Denckla M.B. Neurofibromatosis type 1: The cognitive phenotype. Journal of Pediatrics 124 (1994) S1-S8
14. Hooper H. Hooper Visual Organization Test (1958), Western Psychological Services, Los Angelos, CA
15. Hyman S.L., Gill D.S., Shores E.A., Steinberg A., Joy P., Gibikote S.V., et al. Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1. Neurology 60 (2003) 1139-1145
16. Kesler S.R., Haberecht M.F., Menon V., Warsofsky I.S., Dyer-Friedman J., Neely E.K., et al. Functional neuroanatomy of spatial orientation processing in turner syndrome. Cerebral Cortex 14 2 (2004) 174-180
17. Levine T.M., Rimrodt S.L., Clements-Stephens A.M., and Cutting L.E. Relationship of reading and visuospatial measures in Neurofibromatosis Type 1 [Abstract]. The Clinical Neuropsychologist 20 2 (2006) 215
18. Maldjian J.A., Laurienti P.J., and Burdette J.H. Precentral gyrus discrepancy in electronic versions of the Talairach atlas. NeuroImage 21 1 (2004) 450-455
19. Maldjian J.A., Laurienti P.J., Kraft R.A., and Burdette J.H. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. NeuroImage 19 3 (2003) 1233-1239
20. Moore B.D., and Denckla M.B. Neurofibromatosis. In: Yeates K.O., Ris M.D., and Taylor H.G. (Eds). Pediatric neuropsychology: Research, theory, and practice (1999), Guilford Press, New York 149-170
21. National Institute of Neurological Disorders and Stroke. (2007). Neurofibromatosis fact sheet (NIH Publication No. 06-2126). Bethesda, MD: National Institutes of Health.
22. Ng V.W., Bullmore E.T., de Zubicaray G.I., Cooper A., Suckling J., and Williams S.C.R. Identifying rate-limiting nodes in large-scale cortical networks for visuospatial processing: An illustration using fMRI. Journal of Cognitive Neuroscience 13 (2001) 537-545
23. North K., Joy P., Yuille D., Cocks N., and Hutchins P. Cognitive function and academic performance in children with neurofibromatosis type 1. Developmental Medicine and Child Neurology 37 (1995) 427-436
24. North K., Joy P., Yuille D., Cocks N., Mobbs E., Hutchins P., et al. Specific learning disability in children with neurofibromatosis type 1: Significance of MRI abnormalities. Neurology 44 (1994) 878-883
25. Rao S.M., Salmeron B.J., Durgerian S., Janowiak J.A., Fischer M., Risinger R.C., et al. Effects of methylphenidate on functional MRI blood-oxygen-level-dependent contrast. American Journal of Psychiatry 157 (2000) 1697-1699
26. Schrimsher G.W., Billingsley R.L., Slopis J.M., and Moore III B.D. Visual-spatial performance deficits as a diagnostic indicator in children with neurofibromatosis type-1. American Journal of Medical Genetics 120A 3 (2003) 326-330
27. Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Crivello F., Etard O., Delcroix N., et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage 15 1 (2002) 273-289
28. Wechsler D.L. Wechsler Intelligence Scale for Children III (1991), The Psychological Corporation, San Antonio, TX
29. Wechsler D.L. Wechsler Individual Achievement Test (1992), The Psychological Corporation, San Antonio, TX
30. Woodcock R.W., and Johnson M.B. Woodcock-Johnson Psycho-Educational Battery-Revised (1989), DLM, Allen, TX